The US is the bigger Artificial Intelligence (AI) in Medicine market: $3.5 Bn against $667 Mn in 2023, about 5.2 times as large.
China grows faster: 39% a year, against 35.5%. The gap still grows from $2.8 Bn to $54.8 Bn by 2033.
Clinical research: 642 active trials in the US, 605 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $3.5 Bn | $667 Mn |
| Market size, 2033 projected | $72.7 Bn | $18 Bn |
| Growth a year (CAGR) | 35.5% | 39% |
| Money added, 2023–2033 | $69.2 Bn | $17.3 Bn |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $10 | $0.47 |
| Active clinical trials | 642 | 605 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Artificial Intelligence (AI) in Medicine, US or China?
The US is the bigger Artificial Intelligence (AI) in Medicine market: $3.5 Bn against $667 Mn in 2023, about 5.2 times as large.
Which grows faster in Artificial Intelligence (AI) in Medicine, US or China?
China grows faster: 39% a year, against 35.5%. The gap still grows from $2.8 Bn to $54.8 Bn by 2033.
More Artificial Intelligence (AI) in Medicine comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.